skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can you please give me the Opinion of 5I on Axion Ventures
It is trading on the Venture EX for just 0.95 cents
showing a P/E of only 1.5 (Looks highly profitable)
It is scoring a # 10 on the Thomson Reuters Reports which I checked
on TD Web.Broker.
Appears to be a Good Buy.
Great to see Ryan Modesto on Market Call today.
Thank you
Read Answer Asked by Eric on March 02, 2018
Q: If their first drug, plasminogen gets approval along with a pediatric voucher where do you see the share price. Is it odd that the share price presently is abysmal dropping 30% in a month with the decision due by the FDA no later than mid April. Lastly would you expect a lot of institutional buying for a good run after approval as the risk of the company being viable will be alleviated.
Read Answer Asked by Steve on March 02, 2018
Q: Howdy Team 5i:

Cruz has been receiving attention over recent months as it continues to expand its reach, especially throughout the Ontario region. Would like your analysis on this small cap company and how you feel about the price increase in Cobalt over the past year and its future prospects..

Thanks
Stan
Read Answer Asked by Stan on March 01, 2018
Q: I have too many question to ever use them up, so please consider this three separate queries. I have a high risk tolerance and follow my portfolio extremely closely. Technology is one of the few sectors performing well recently and I would like your opinion on whether these would be investments or gambles. Are any of these worth a full position (5%) or a half position. Or are there ideas you currently like better.
Thanks for all you do, this service is the reason I'm retired.
Read Answer Asked by Kyle on March 01, 2018
Q: It has been almost a year since you commented on this company so I would appreciate it if you provide an update. To be specific, what do you think of their latest results from 22 February (see highlights below)? Many thanks.

Highlights during the First Quarter

Revenue increased 222% to $2.2 million compared to the same period last year. Paid development contracts continued to drive the period over period revenue growth.
Gross margins were 75%, down from 83% in the same period last year. Gross margins continue to reflect strong margins from development contracts and were slightly impacted by lower margin revenue from the Thurso operations.
Adjusted EBITDA(1) reached $460,000. The Company recorded its third consecutive quarter of positive Adjusted EBITDA, a notable improvement from the $556,000 negative Adjusted EBITDA reported for the same period last year.
Achieved positive net income of $96,000. Strong revenues and gross margins resulted in positive net income, a significant change from the net loss of $1.9 million reported for the same period last year.
Cash balance of $10.9 million at quarter-end. The Company finished the quarter with a strong cash position and no debt or warrants outstanding.
Read Answer Asked by karl on March 01, 2018
Q: What are your current overall thoughts on AT? also what do you think of today's acquisition ? the market seems to like it. Would you be comfortable with a 2-3% holding of AT?

thanks Tom
Read Answer Asked by Tom on February 28, 2018
Q: Hi there

I have owned Corbys for quite a while and use it as a steady eady income stock. It would appear to be currently paying out more than its earnings by my brokers figures which isn't good. In the past it has paid special dividends. I see it has dropped in price to a 52 week low. I was thinking of adding to my position believing the price may rise over the next year. What do you think of Corbys going forward? Do you see it dropping further in price or more likely being a couple of dollars more in a years time?

Thanks

Stuart
Read Answer Asked by Stuart on February 28, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!